Rankings
▼
Calendar
APGE Q1 2023 Earnings — Apogee Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
APGE
Apogee Therapeutics, Inc.
$4B
Q1 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$13M
Net Income
-$13M
EPS (Diluted)
$-0.25
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$11M
Free Cash Flow
-$11M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$142M
Total Liabilities
$11M
Stockholders' Equity
$131M
Cash & Equivalents
$141M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$13M
-$4M
-194.0%
Net Income
-$13M
-$4M
-190.9%
← FY 2023
All Quarters
Q2 2023 →